With 'breakthrough' skin cancer drug, small S.F. drug maker lands European cash
November 20, 2018 at 10:05 AM EST
To deal with tumors on the face today, patients with Gorlin Syndrome can have as many as 30 surgical procedures a year. PellePharm, with the help of an investment by Danish drug maker Leo Pharma, believes its experimental twice-a-day ointment can change that.
